Health Canada is warning people that unauthorized sexual enhancement products sold in at least three provinces may pose ...

Health Canada must reassess its approval of a popular pesticide after a federal judge ruled its renewed registration was ...

Health Canada has approved MSD's anti-programmed cell death protein 1 (PD-1) therapy Keytruda for treating adults with ...

The federal government has been ordered to reassess its 2022 approval of a popular weed-killer after a Federal Court judge ...

Health Canada recently published draft regulations to address therapeutic product shortages in Canada. The Regulations Amending Certain ...

Approved by Health Canada, Kabrita’s gentle, easy-to-digest infant formula is ideal for all healthy term babies 0-12 months ...

Health Canada’s 2022 decision to approve the glyphosate-based herbicide Mad Dog Plus was found to be unreasonable.

Indaptus Therapeutics (INDP) announced the Company has received Clinical Trial Authorization from Health Canada to initiate its clinical trial ...

(RTTNews) - Merck (MRK) announced that Health Canada has granted approval for KEYTRUDA, Merck's anti-PD-1 therapy, as a treatment for adult patients with resectable Stage II, IIIA, or IIIB non ...

Health Canada’s approval followed a comprehensive review of our safety data and trial design. Expanding to Canada represents a significant step in our mission to evaluate Decoy20, a broad immune ...